how big is DMCC Speciality?

As of Jun 06, DMCC Speciality Chemicals Ltd has a market capitalization of 668.39 Cr, classifying it as a Micro Cap company, with recent net sales of 431.31 Cr and a net profit of 21.52 Cr over the last four quarters. The latest balance sheet shows shareholder's funds at 209.54 Cr and total assets of 364.72 Cr.

Market Cap: As of Jun 06, DMCC Speciality Chemicals Ltd has a market capitalization of 668.39 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the sum of Net Sales is 431.31 Cr and the sum of Net Profit is 21.52 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'24. The Shareholder's Funds are reported at 209.54 Cr, and the Total Assets amount to 364.72 Cr.

Who are in the management team of DMCC Speciality?

As of March 2023, the management team of DMCC Speciality includes Laxmikumar N Goculdas (Chairman), Dilip Trimbak Gokhale (Whole-time Director), Bimal L Goculdas (Managing Director & CEO), and several independent directors, overseeing the company's operations and strategy.

As of March 2023, the management team of DMCC Speciality consists of the following individuals:<BR><BR>1. Laxmikumar N Goculdas - Chairman (Non-Executive)<BR>2. Dilip Trimbak Gokhale - Whole-time Director<BR>3. M T Ankleshwaria - Independent Director<BR>4. Mitika Laxmikumar Goculdas - Vice Chairperson<BR>5. Sanjeev Vishwanath Joshi - Independent Director<BR>6. Mukul Manoharlal Taly - Independent Director<BR>7. Bimal L Goculdas - Managing Director & CEO<BR>8. Janaki Ashwin Patwardhan - Independent Director<BR>9. Omkar Chandrakant Mhamunkar - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does DMCC Speciality do?

DMCC Speciality Chemicals Ltd, established in 1919 and rebranded in 2022, operates in the specialty chemicals sector with a market cap of Rs 668 Cr, reporting net sales of 125 Cr and a net profit of 6 Cr for Q1 2025. Key metrics include a P/E ratio of 31.00 and a dividend yield of 0.37%.

Overview:<BR>DMCC Speciality Chemicals Ltd is a pioneer in the specialty chemicals industry and operates within the micro-cap market segment.<BR><BR>History:<BR>The company was incorporated in 1919 as 'Dharamsi Morarji Chemicals Company Limited' and changed its name to 'DMCC Speciality Chemicals Limited' on August 12, 2022. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 125 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 6 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: Rs 668 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 31.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.37%<BR>- Debt Equity: 0.18<BR>- Return on Equity: 9.46%<BR>- Price to Book: 2.96<BR><BR>Contact Details:<BR>Address: Prospect Chambers, 317/21 Dr D N Road Fort Mumbai Maharashtra : 400001<BR>Tel: 91-22-22048881/2/3<BR>Email: dgokhale@dmcc.com<BR>Website: http://www.dmcc.com

Has DMCC Speciality declared dividend?

Yes, DMCC Speciality Chemicals Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of August 28, 2024. While the company shows significant volatility in total returns over shorter periods, it has achieved a total return of 235.49% over the past five years.

DMCC Speciality Chemicals Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1<BR>- Ex-date: 28 Aug 24<BR><BR>Dividend Yield: 0.37%.<BR><BR>Total Returns by Period:<BR>Over the last 6 months, the price return was -29.58%, with a dividend return of 0%, resulting in a total return of -29.58%.<BR><BR>In the past year, the price return was -13.21%, the dividend return was 0.31%, leading to a total return of -12.9%.<BR><BR>Over two years, the price return was 4.57%, with a dividend return of 0.37%, resulting in a total return of 4.94%.<BR><BR>For the three-year period, the price return was -26.25%, the dividend return was 0.62%, culminating in a total return of -25.63%.<BR><BR>In the four-year timeframe, the price return was -18.72%, with a dividend return of 0.77%, leading to a total return of -17.95%.<BR><BR>Finally, over five years, the price return was 230.67%, the dividend return was 4.82%, resulting in a total return of 235.49%.<BR><BR>Overall, while DMCC Speciality has declared a dividend, the total returns over various periods show significant volatility, with a notable decline in returns over shorter periods, contrasting with strong returns over the longer five-year horizon.

Who are the peers of the DMCC Speciality?

DMCC Speciality's peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Amal, Kronox Lab, Sunshield Chem., and Plastiblends (I). In terms of returns, DMCC Speciality has a 1-year return of -15.66%, lower than its peers, with Amal showing the highest return at 49.47%.

Peers: The peers of DMCC Speciality are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Amal, Kronox Lab, Sunshield Chem., and Plastiblends (I).<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, while Good management risk is found at Pidilite Inds. and SRF. Average management risk is present at Gujarat Fluoroch, Himadri Special, DMCC Speciality, Amal, Kronox Lab, Sunshield Chem., and Black Rose Indus. Growth is classified as Good for Himadri Special and Amal, Average for Pidilite Inds. and SRF, and Below Average for Gujarat Fluoroch, Deepak Nitrite, DMCC Speciality, Kronox Lab, Sunshield Chem., Plastiblends (I), and Black Rose Indus. Capital Structure is Excellent for Pidilite Inds., SRF, Deepak Nitrite, and Plastiblends (I), Good for Gujarat Fluoroch, Himadri Special, and DMCC Speciality, Average for Amal, and Below Average for Sunshield Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Amal at 49.47%, while the lowest is Deepak Nitrite at -9.64%. DMCC Speciality's 1-year return is -15.66%, which is lower than both. Additionally, the six-month return is negative for Deepak Nitrite, Himadri Special, DMCC Speciality, Kronox Lab, Sunshield Chem., and Black Rose Indus.

Who are the top shareholders of the DMCC Speciality?

The top shareholder of DMCC Speciality is Laxmikumar Narottam Goculdas, holding 36.27%, followed by individual investors with 33.75%. Other notable shareholders include Girish Gulati (HUF) at 2.28%, with minimal holdings from mutual funds (0.01%) and foreign institutional investors (1.16%).

The top shareholders of DMCC Speciality include Laxmikumar Narottam Goculdas, who holds the largest share at 36.27%. The company is primarily owned by promoters, with no pledged promoter holdings reported. Additionally, there are individual investors who collectively hold 33.75% of the shares. The highest public shareholder is Girish Gulati (HUF), with a holding of 2.28%. The company also has a small percentage of shares held by mutual funds (0.01%) and foreign institutional investors (1.16%) across six different entities.

When is the next results date for DMCC Speciality?

The next results date for DMCC Speciality is 11 November 2025.

The next results date for DMCC Speciality is scheduled for 11 November 2025.

Is DMCC Speciality technically bullish or bearish?

As of November 6, 2025, DMCC Speciality's trend has shifted to mildly bearish, influenced by bearish signals from MACD, KST, and Bollinger Bands, despite some support from daily moving averages and underperformance compared to the Sensex.

As of 6 November 2025, the technical trend for DMCC Speciality has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD and KST both indicating mild bearishness, alongside bearish signals from the Bollinger Bands on both weekly and monthly time frames. The daily moving averages remain mildly bullish, providing some support, but the overall trend is weakened by the lack of momentum in the RSI and the Dow Theory showing no trend on a monthly basis. The stock has underperformed compared to the Sensex over multiple time frames, particularly in the last month and year.

Are DMCC Speciality latest results good or bad?

DMCC Speciality Chemicals reported a 22.68% increase in sales to ₹126.03 crores, indicating market share growth; however, declining operating margins and net profit raise concerns about profitability and operational efficiency. Overall, the results are mixed and suggest the need for management to address these challenges.

The latest results for DMCC Speciality Chemicals indicate a mixed performance, with some concerning trends. On the positive side, the company achieved a 22.68% year-on-year increase in sales, reaching ₹126.03 crores. This demonstrates its ability to capture market share in the specialty chemicals sector.<BR><BR>However, the financial health of the company shows significant challenges. Operating margins have compressed to 11.12%, the lowest in recent quarters, which indicates deteriorating operational efficiency. This margin compression is a critical concern, as it suggests that rising input costs and operational inefficiencies are impacting profitability despite the revenue growth. <BR><BR>Net profit for the quarter was ₹5.75 crores, reflecting a decline of 1.03% year-on-year and a more significant drop of 25.90% compared to the previous quarter. The PAT margin also decreased to 4.56%, down from 5.66% a year earlier. <BR><BR>In summary, while DMCC has demonstrated revenue growth, the accompanying decline in margins and profitability raises red flags about its operational effectiveness and ability to sustain earnings growth. Overall, the results can be viewed as concerning, highlighting the need for management to address these operational challenges to improve financial performance moving forward.

How has been the historical performance of DMCC Speciality?

DMCC Speciality's historical performance shows significant growth in net sales, rising from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, alongside increases in profit metrics and stable cash flow, despite rising raw material costs. Total assets and liabilities were balanced at INR 371.92 crore in March 2025.

Answer:<BR>The historical performance of DMCC Speciality shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>DMCC Speciality's net sales increased significantly from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, following a dip in March 2023 when sales were INR 386.65 crore. The total operating income mirrored this trend, reaching INR 431.30 crore in March 2025. However, raw material costs also rose to INR 259.09 crore in March 2025 from INR 195.51 crore in March 2024, contributing to a total expenditure of INR 374.28 crore. Operating profit before depreciation and interest (PBDIT) improved to INR 57.02 crore in March 2025, up from INR 36.27 crore in March 2024, while profit before tax increased to INR 31.14 crore from INR 17.25 crore. The profit after tax also saw a rise to INR 21.53 crore in March 2025 compared to INR 11.59 crore in March 2024. The company's total assets stood at INR 371.92 crore in March 2025, with total liabilities at INR 371.92 crore as well, indicating a balanced financial position. Cash flow from operating activities remained stable at INR 38.00 crore in March 2025, consistent with the previous year, while the closing cash and cash equivalents increased to INR 4.00 crore from INR 2.00 crore in March 2024.

Is DMCC Speciality overvalued or undervalued?

As of November 19, 2025, DMCC Speciality is considered very attractive and undervalued compared to peers in the specialty chemicals sector, with favorable key ratios indicating strong growth potential despite a recent year-to-date return of -27.89%.

As of 19 November 2025, the valuation grade for DMCC Speciality has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the specialty chemicals sector. Key ratios include a PE ratio of 23.89, an EV to EBITDA of 11.02, and a PEG ratio of 0.22, which suggests strong growth potential relative to its price.<BR><BR>In comparison with peers, DMCC Speciality's valuation stands out favorably against companies like Solar Industries, which has a PE ratio of 94.38, and Gujarat Fluoroch, with a PE ratio of 56.8, both categorized as very expensive. This stark contrast highlights DMCC's relative attractiveness in the market. Despite recent underperformance with a year-to-date return of -27.89% compared to the Sensex's 9.02%, the fundamental metrics suggest that DMCC Speciality is positioned well for future growth and recovery.

Should I buy, sell or hold DMCC Speciality?

Which are the latest news on DMCC Speciality?

Why is DMCC Speciality falling/rising?

As of 03-Dec, DMCC Speciality Chemicals Ltd's stock price is rising to 273.15, reflecting a 2.53% increase. This rise is driven by strong investor interest, positive financial results, and an undervalued stock relative to its earnings growth potential.

As of 03-Dec, DMCC Speciality Chemicals Ltd's stock price is rising, currently at 273.15, reflecting an increase of 6.75 (2.53%). This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 3.82% today and has been on a consecutive gain streak for the last three days, accumulating a total return of 6.06% during this period. Additionally, the stock reached an intraday high of Rs 279.1, indicating strong trading activity.<BR><BR>Investor participation has also increased, with a delivery volume of 23.63k on December 2, which is a significant rise of 125.82% compared to the 5-day average delivery volume. This suggests heightened interest and confidence among investors. Furthermore, the company has reported positive financial results over the last five consecutive quarters, with a 54.29% growth in profit after tax and a 39.07% increase in net sales for the nine-month period. The return on capital employed (ROCE) is also strong at 17.4, indicating attractive valuation metrics.<BR><BR>Despite a challenging year with a -27.14% return, the company's profits have risen significantly, leading to a favorable PEG ratio of 0.2, suggesting that the stock is undervalued compared to its earnings growth potential. Overall, these factors contribute to the stock's rising price as investors respond positively to the company's financial performance and market activity.